Seed Round - Bicara Therapeutics
Investment Firm
Overview
Bicara Therapeutics develops dual-action cancer therapies, combining targeted treatments with tumor modulators for enhanced impact.
Announced Date
Mar 15, 2021
Funding Type
Seed
Highlights
Location
United States, North America
Social
Investor Lead
Participant Investors
1
| Investor Name |
|---|
 Biocon |
Round Details and Background
Bicara Therapeutics raised $40000000 on 2021-03-15 in Seed Round
Bicara Therapeutics develops dual-action cancer therapies, combining targeted treatments with tumor modulators for enhanced impact.
Company Funding History
3
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Mar 15, 2021 |  Seed Round - Bicara Therapeutics | 1 | - | 40.0M |
| Mar 06, 2023 | Series B - Bicara Therapeutics | 12 | - | 108.0M |
| Dec 12, 2023 | Series C - Bicara Therapeutics | 18 | - | 165.0M |
Recent Activity
There is no recent news or activity for this profile.